Print this article
P. 2-3 /

The new direction of R&D in drug development

Keywords:

COLIN TERRY
Executive vice president, Commercial operations
Aptuit, Unit 107 Tenth Avenue, Deeside Industrial Estate, Flintshire, CH52UA, United Kingdom

In July, GlaxoSmithKline (GSK) transferred its researchoperations in Verona, Italy to Aptuit, a global drugdevelopment organization basedi n Greenwich, Connec t i c u t .Beyond the significance of thetransaction i t self to each ofthese businesses, the structure ofthis deal is indicative of a broadertrend of Big Pharma taking steps toreshape their approach to clinical development.